We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 789

The State AG Report Weekly Update December 14, 2017
  • Cozen O'Connor
  • USA
  • December 14 2017

Republican state Representative Todd Atwater has declared his candidacy for South Carolina AG in 201

Washington Healthcare Update - Oct 30, 2017
  • McGuireWoods LLP
  • USA
  • October 30 2017

Rep. Elijah Cummings (D-MD) and Sen. Bernie Sanders (I-VT) introduced legislation on Oct. 25 to let the government negotiate drug prices in Medicare

Washington Healthcare Update - Aug 7, 2017
  • McGuireWoods LLP
  • USA
  • August 7 2017

On July 31 the House Problem Solvers Caucus, a group comprising an even number of Democrats and Republicans, released a plan to fix the ACA. The plan

Washington Healthcare Update - Jul 17, 2017
  • McGuireWoods LLP
  • USA
  • July 17 2017

Earlier this week, House Energy & Commerce Oversight Subcommittee announced a hearing date has been set to discuss the 340B Drug Discount Program on

340B Update: Draft Executive Order Could Mean Changes to the 340B Program
  • K&L Gates
  • USA
  • July 13 2017

An early draft of the Trump administration’s proposed executive order (“EO”) on drug pricing issues could result in significant changes to the 340B

User Fee Reauthorization Picks Up Steam
  • Cooley LLP
  • USA
  • July 11 2017

In preparation for a vote this week, the House of Representatives Committee on Energy and Commerce yesterday released a new draft of the user fee

Washington Healthcare Update - Jul 3, 2017
  • McGuireWoods LLP
  • USA
  • July 3 2017

The House Appropriations Subcommittee for Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies released their

Capitol Hill Healthcare Update
  • Baker & Hostetler LLP
  • USA
  • June 26 2017

Senate Republican leaders are expected to make a series of changes to the healthcare legislation released Thursday as they scramble to gain the

House Energy & Commerce Committee Unanimously Approves FDA Reauthorization, Public Health Bills
  • Reed Smith LLP
  • USA
  • June 15 2017

On June 8, 2017, the Energy and Commerce Committee voted unanimously to approve an amended version of HR 2430, the FDA Reauthorization Act (FDARA) of

Washington Healthcare Update - June 12, 2017
  • McGuireWoods LLP
  • USA
  • June 12 2017

On June 7, the House Energy and Commerce Committee reported out a bill reauthorizing FDA user fee programs for drugs and medical devices in a